HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joshua Brody Selected Research

ON123300

3/2016Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joshua Brody Research Topics

Disease

19Neoplasms (Cancer)
11/2021 - 07/2004
8Lymphoma (Lymphomas)
12/2020 - 09/2009
5Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2020 - 09/2009
4Hematologic Neoplasms (Hematological Malignancy)
12/2020 - 01/2013
3Hodgkin Disease (Hodgkin's Disease)
12/2020 - 03/2013
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2020 - 02/2019
2Neoplasm Metastasis (Metastasis)
10/2020 - 06/2013
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2019 - 02/2013
2Multiple Myeloma
03/2016 - 01/2016
2Leukemia
01/2016 - 01/2016
1Cytokine Release Syndrome
10/2020
1Rupture
10/2020
1Hemorrhagic Shock
10/2020
1Erythema Nodosum
06/2020
1Exanthema (Rash)
02/2019
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2019
1Melanoma (Melanoma, Malignant)
04/2016
1Primary Myelofibrosis (Myelosclerosis)
01/2016
1Anemia
09/2014
1Brain Abscess (Abscess, Brain)
01/2013
1Neurosarcoidosis
01/2013
1Cerebral Phaeohyphomycosis
01/2013
1Tetanus
05/2008
1Heart Block
09/2007
1Burkitt Lymphoma (Burkitt's Lymphoma)
09/2007

Drug/Important Bio-Agent (IBA)

4Monoclonal AntibodiesIBA
05/2012 - 06/2006
2Biomarkers (Surrogate Marker)IBA
10/2020 - 05/2020
2Vincristine (Oncovin)FDA LinkGeneric
05/2020 - 04/2019
2Phosphotransferases (Kinase)IBA
01/2017 - 03/2016
2AntigensIBA
04/2016 - 07/2004
2AntibodiesIBA
06/2013 - 05/2011
2VaccinesIBA
05/2011 - 09/2009
1Immunoglobulins (Immunoglobulin)IBA
12/2020
1varlilumabIBA
12/2020
1Biological ProductsIBA
10/2020
1durvalumabIBA
10/2020
1MEDI9197IBA
10/2020
1Etanercept (Enbrel)FDA Link
06/2020
1Tyrosine Kinase InhibitorsIBA
06/2020
1Prednisone (Sone)FDA LinkGeneric
05/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2020
1enzastaurinIBA
05/2020
1Rituximab (Mabthera)FDA Link
05/2020
1Alanine Transaminase (SGPT)IBA
02/2019
1NivolumabIBA
02/2019
1ibrutinibIBA
02/2019
1Chimeric Antigen ReceptorsIBA
01/2017
1Syk KinaseIBA
01/2017
1Immunoglobulin FragmentsIBA
01/2017
1Immunologic Factors (Immunomodulators)IBA
01/2017
1Phospholipases (Phospholipase)IBA
01/2017
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
01/2017
1src-Family KinasesIBA
01/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2016
1Poly I-CIBA
04/2016
1ON123300IBA
03/2016
1Protein Kinases (Protein Kinase)IBA
03/2016
1Thrombopoietin ReceptorsIBA
01/2016
1Thrombopoietin (c-mpl Ligand)IBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
02/2015
1ErythropoietinFDA Link
09/2014
1NucleotidesIBA
06/2013
1LigandsIBA
02/2013
1CytokinesIBA
02/2013
1SteroidsIBA
01/2013
1Transcription Factors (Transcription Factor)IBA
01/2013
1CateninsIBA
01/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2011
1Cytidine Monophosphate (CMP)IBA
05/2008
1Radioisotopes (Radionuclides)IBA
06/2006
1Neoplasm Antigens (Tumor Antigens)IBA
07/2004

Therapy/Procedure

15Therapeutics
12/2020 - 06/2006
9Immunotherapy
11/2021 - 09/2009
4Drug Therapy (Chemotherapy)
04/2019 - 06/2006
1Radiotherapy
10/2020
1Bridge Therapy
04/2019
1Injections
04/2016
1Immunomodulation
06/2013
1Aftercare (After-Treatment)
09/2007
1Combination Drug Therapy (Combination Chemotherapy)
06/2006
1Stem Cell Transplantation
06/2006